The store will not work correctly when cookies are disabled.
8,13(15)-Abietadien-18-ol
ID: ALA553410
PubChem CID: 14446483
Max Phase: Preclinical
Molecular Formula: C20H32O
Molecular Weight: 288.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)=C1CCC2=C(CC[C@H]3[C@](C)(CO)CCC[C@]23C)C1
Standard InChI: InChI=1S/C20H32O/c1-14(2)15-6-8-17-16(12-15)7-9-18-19(3,13-21)10-5-11-20(17,18)4/h18,21H,5-13H2,1-4H3/t18-,19-,20+/m0/s1
Standard InChI Key: IROXAKIPGBQTGG-SLFFLAALSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
15.1989 -7.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1989 -8.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9101 -8.5848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9101 -6.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6256 -7.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6267 -8.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3383 -8.5838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0534 -8.1724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3362 -6.9326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0550 -7.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7683 -6.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7691 -6.1037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0503 -5.6905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3307 -6.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6176 -6.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6176 -8.9907 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
19.4800 -5.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1912 -6.1032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4796 -4.8718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1158 -9.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3221 -9.1640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9075 -9.5918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
1 2 1 0
1 4 1 0
9 14 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
2 3 1 0
5 15 1 1
5 9 1 0
6 16 1 6
6 7 1 0
12 17 2 0
7 8 1 0
17 18 1 0
8 10 1 0
17 19 1 0
9 10 2 0
3 20 1 6
3 6 1 0
3 21 1 0
5 4 1 0
20 22 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.48 | Molecular Weight (Monoisotopic): 288.2453 | AlogP: 5.40 | #Rotatable Bonds: 1 |
Polar Surface Area: 20.23 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 1 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.39 | CX LogD: 4.39 |
Aromatic Rings: ┄ | Heavy Atoms: 21 | QED Weighted: 0.64 | Np Likeness Score: 2.95 |
References
1. González MA, Correa-Royero J, Agudelo L, Mesa A, Betancur-Galvis L.. (2009) Synthesis and biological evaluation of abietic acid derivatives., 44 (6): [PMID:19217699] [10.1016/j.ejmech.2009.01.014] |